| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
*
First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Japan, Kitakyushu, Japan; and
Department of Pathology, University of Birmingham, Birmingham, United Kingdom
 |
Abstract |
|---|
 Top Abstract IntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
and TNF-
did; 3) the Fas-mediated early apoptotic change of the
cells was amplified by CD44 cross-linking; and 4) hyaluronan,
especially when fragmented, also augmented Fas-mediated early apoptosis
of the cells. Based on these findings, we postulate a new concept: that
interaction of CD44 on RA synovial cells with hyaluronan fragments
present in the surrounding extracellular matrix augments Fas expression
as well as Fas-mediated apoptosis of synovial cells. This may lead to
spontaneous growth arrest through Fas-Fas ligand pathway observed in
synovial cells of RA synovitis in vivo. |
Introduction |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
Fas is a widely expressed 45-kDa cell surface Ag of the TNF/nerve growth factor receptor superfamily (7, 8, 9) and is also known to be a target gene of p53, and the p53 mediates down-regulation of bcl-2, which results in cell cycle arrest and subsequent apoptosis. Recent report identified the expression of Fas and presence of apoptotic change of RA synovial cells, suggesting the role of Fas-mediated apoptosis in the inhibition of synovial hyperplasia (1). Thus, these paradoxical features of RA synovium associated with imbalance between cell proliferation and cell death appear to be most relevant to pathological processes of RA synovitis. However, mechanisms of regulating Fas expression and Fas-mediated apoptosis of proliferating rheumatoid synovial fibroblasts are largely unknown.
Overexpression of adhesion molecules, including ICAM-1, VCAM-1, and
CD44, is a hallmark of the inflammatory responses such as RA synovitis
(10, 11, 12). Adhesion molecules play a fundamental role in
inflammatory processes by mediating leukocyte-endothelial cell
adhesion, leukocyte migration, and T cell-APC interactions. However,
recent findings have indicated that certain adhesion molecules not only
function as glue, but also regulate several cellular functions by
transducing signaling. We have reported that ICAM-1 and CD44 on
rheumatoid synovial cells induced transcription of IL-1 and VCAM-1,
respectively, by activation of a nuclear factor, AP-1 (13, 14). These results have prompted us to investigate the adhesion
molecules involved in Fas up-regulation on rheumatoid synovial cells.
Cross-linking multiple adhesion molecules, such as LFA-1, VLA-4,
ICAM-1, and CD44, on rheumatoid synovial cells, we report in this work
that CD44 was unique in its remarkable up-regulation of Fas expression
on synovial cells. Among multiple cell surface receptors for the
matrix, CD44, which is a receptor for hyaluronan, a major matrix
polysaccharide abundantly existing in synovium, is overexpressed in
inflammatory sites in proportion to the intensity of inflammation,
implicating CD44 in the pathogenesis of inflammation (10).
This report documents a role for CD44 and its ligand hyaluronan in Fas
up-regulation on rheumatoid synovial cells. We propose a model for the
involvement of an adhesion molecule CD44 in the induction of Fas
expression on synovial cells and the subsequent amplification of
Fas-mediated apoptosis of the cells in inflammatory processes of RA
synovitis.
|
Materials and Methods |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
Synovial tissues were obtained from patients with active RA, diagnosed according to the criteria of the American College of Rheumatology, who were treated by joint replacement surgery or synovectomy. Samples were dissected under sterile conditions in PBS, and immediately prepared for culture of fibroblast-like synovial cells. Briefly, the tissue sample was minced into small pieces and digested with collagenase (Sigma Aldrich Japan, Tokyo, Japan) in serum-free DMEM (Life Technologies, Grand Island, NY). After filtering through a nylon mesh, the cells were extensively washed, and suspended in DMEM, supplemented with 10% FCS (Bio-Pro, Karlsruhe, Germany) and penicillin-streptomycin (10 U/ml; Sigma Aldrich). Finally, isolated cells were seeded in 25-cm2 culture flasks (Falcon, Lincoln Park, NJ) and cultured in a humidified 5% carbon dioxide atmosphere. After overnight culture, nonadherent cells were removed, and further incubation of adherent cells was continued in fresh medium. At confluence, the cells were trypsinized, passaged at a 1:3 split ratio, and recultured. The medium was changed twice each week, and the cells were used after three to seven passages.
Reagents and mAbs
IL-1, TNF- (Cosmobio, Tokyo, Japan), annexin V
(Immunotech, Marseille, France), and IgM anti-Fas mAb (MBL, Nagoya,
Japan) were purchased. Fragmented and native hyaluronan were kindly
donated by the Tokyo Research Institute of Seikagaku (Tokyo,
Japan). The following mAbs were used as purified Igs: CD14 (mAb
63D3), anti-glycophorin (mAb 10F7; American Type Culture
Collection, Manassas, VA), control mAb (Thy-1.2; Becton Dickinson, San
Jose, CA), MHC class II (mAb IVA12; a gift from Dr. J. D. Capra,
Dallas, TX), CD11b (mAb NIH11b-1), CD44 (mAb NIH44-1), and CD54
(ICAM-1) (mAb 84H10); gifts from Dr. S. Shaw, Bethesda,
MD).
Stimulation of CD44 of synovial cells
Synovial cells were cultured until subconfluence and then incubated with CD44 mAb NIH44-1 (10 µg/ml) for 30 min at 37°C, as already described (8). After washing the cells three times, 1 µg/ml goat anti-mouse IgG-Fc was added as the second Ab for CD44 cross-linking. The cells were cultured until subconfluence and then also incubated with fragmented or native hyaluronan (0.1 µg/ml) for 3 h at 37°C.
Flow microfluorometry
Staining and flow cytometric analysis of synovial cells were conducted by standard procedures, as already described, using a FACScan (Becton Dickinson, Mountain View, CA) (15, 16). Briefly, cells (2 x 105) were incubated with FITC-conjugated specific mAbs at saturating concentrations in the presence of goat anti-mouse irrelevant Ab in FACS medium consisting of HBSS (Nissui, Tokyo, Japan), 0.5% human serum albumin (Green-cross, Osaka, Japan), and 0.2% NaN3 (Sigma Aldrich) for 30 min at 4°C. After three washes in FACS medium, the cells were analyzed with FACScan. Amplification of the mAb binding was provided by a three-decade logarithmic amplifier. Quantification of the cell surface Ags on one cell was performed using beads, QIFKIT (Dako Japan, Kyoto, Japan). Briefly, five populations of calibration beads, bearing different, but well-defined numbers of mAb molecules, were analyzed by FACScan. Mean fluorescence intensity of each population of beads was used for construction of the calibration curve. The cell specimen was analyzed by FACScan, and Ag density was calculated by interpolation on calibration curve.
Northern blot analysis
For Northern blot analysis, total cellular RNA was isolated from cultured RA synovial cells by a single-step isolation procedure. The RNA (10 µg) was electrophoresed through a 1% agarose gel and blotted onto nylon filters (Amersham, Arlington Heights, IL). Fas cDNA (Biognostik, Gottingen, Germany) was labeled with [32P]dCTP (Dupont NEN, Boston, MA), and Northern blot analysis was subsequently performed.
Statistical analysis
Significant differences among groups within each experiment were determined by ANOVA, followed by post hoc Scheffé’s F test.
|
Results |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
We initially characterized cultured synovial cells derived from
the synovium of RA patients. The cells were spindle shaped and grew in
a cobblestone pattern. Flow cytometric analysis of these cells in a
confluent culture indicated that they lacked macrophage markers such as
MHC class II Ags, CD14, and CD11b, suggesting they are type B
fibroblast-like cells (Fig. 1
). These
fibroblast-like cells express Fas in monomodal pattern as well as CD44.
CD44 was positive on all the synovial cells examined by FACScan, and 17
of 20 CD44 positive cells also coexpressed Fas.
|
To characterize the function of CD44, we assayed the cell surface
molecule expression by CD44 cross-linking using a specific mAb and
second cross-linker Ab. Flow cytometry showed that Fas expression was
markedly augmented by the CD44 cross-linking on synovial cells. As
shown in Fig. 2 and Table I, Fas was moderately expressed on
nonstimulated synovial cells. However, CD44 cross-linking significantly
up-regulated Fas expression, whereas cross-linking of ICAM-1 using its
specific mAb had no effect. The results were consistent in five
patients with RA. Time-course experiments showed that Fas expression on
RA synovial cells reached maximum levels within 3 h of CD44
cross-linking, but the expression returned to almost basal levels after
24 h of incubation (Fig. 3). The
results indicate that the CD44 cross-linking induced a marked, but
transient amplification of Fas expression on RA synovial cells.
|
|
|
CD44 cross-linking also induced transcription of Fas mRNA in RA
synovial cells. After CD44 cross-linking, RNA was extracted from RA
synovial cells, and specific mRNA was detected by Northern blot
analysis using primers specific for human Fas. RA synovial cells barely
expressed Fas mRNA without stimulation. CD44 cross-linking markedly
augmented Fas mRNA transcription, which was maximal within 2 h of
stimulation, but subsequently gradually diminished (Fig. 4).
|
IL-1 is known to induce Fas expression on pancreatic cells
(9). In the next series of experiments, we compared the
magnitude of Fas up-regulation induced by CD44 and other stimuli,
including several cytokines on synovial cells. When CD44 was
cross-linked by specific mAb and second cross-linker Ab, the expression
of Fas on RA synovial cells was markedly augmented, whereas cytokines
such as IL-1 and TNF-, which are known to be abundantly produced
in RA synovium and to be involved in the pathogenesis of RA synovitis,
had no effect on Fas expression at 3 h of stimulation of RA
synovial cells (Fig. 5A). When
ICAM-1, MHC-class I, or VCAM-1 Ag were cross-linked by their specific
mAb and second cross-linker Ab, the expression of Fas on RA synovial
cells was unchanged, whereas CD44 cross-linking markedly augmented Fas
expression (Fig. 5B). All these studies were reproducible
among three different RA patients. These results suggest that CD44
appears to play a pivotal role in Fas up-regulation on the cell surface
during inflammatory process like rheumatoid synovitis.
|
Apoptosis of RA synovial cells is known to be induced by
anti-Fas mAb. We next investigated the effect of CD44-induced Fas
up-regulation on Fas-mediated apoptosis of RA synovial cells.
Stimulation of RA synovial cells with anti-Fas mAb induced early
apoptotic change of RA synovial cells, which was detected by double
staining with propidium iodide (PI) and annexin V and stained with
PIlow annexin Vhigh,
whereas CD44 cross-linking alone had no effect and the vast majority of
the cells remained PIlow annexin
Vlow. Cross-linking of CD44, followed by Fas mAb
stimulation, markedly increased the number of
PIlow annexin Vhigh, early
apoptotic synovial cells (Fig. 6 and
Table II). These results suggest that Fas
up-regulation by CD44 may contribute to the augmentation of
Fas-mediated apoptosis of RA synovial cells.
|
|
Hyaluronan is a major ligand for cell surface CD44. We finally
assessed the biological activity of hyaluronan on Fas-induced early
apoptosis of RA synovial cells. As shown in Fig. 7 and Table II
, soluble full-length
hyaluronan had almost no effect on apoptotic change of RA synovial
cells, and the vast majority of the cells remained
PIlow annexin Vlow.
However, the 6.9-kDa fragmented hyaluronan apparently increased the
Fas-mediated early apoptotic change of RA synovial cells,
PIlow annexin Vhigh cells.
Fragmented hyaluronan, but not full-length hyaluronan, also enhanced
Fas expression (data not shown). This suggests that hyaluronan,
especially when fragmented, is a possible ligand augmenting
Fas-mediated apoptosis of RA synovial cells.
|
|
Discussion |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
and
TNF-; 2) Fas-mediated apoptosis of RA synovial cells was markedly
augmented by the CD44 cross-linking on synovial cells; and 3)
fragmented hyaluronan effectively augmented Fas-mediated apoptosis
compared with native hyaluronan. Based on these findings, we postulate
a new concept, that interaction of CD44 on RA synovial cells with
fragments of extracellular hyaluronan present in the surrounding
extracellular matrix augments Fas expression and Fas-mediated apoptosis
of synovial cells.
Recent findings indicate that certain adhesion molecules not only
function as a glue, but also regulate several cellular functions by
transducing signals. Several reports demonstrate that
cell-extracellular matrix adhesion also regulates Fas expression. For
example, interaction of type IV collagen and epithelial cells augments
Fas expression and enhances Fas-mediated apoptosis (21).
From a survey of cross-linking of multiple adhesion molecules, we found
that one such molecule, CD44, was unique in its remarkable
up-regulation of Fas expression on synovial cells and enhancement of
Fas-mediated apoptosis of them. The principal known ligand for CD44 is
hyaluronan, which is a high m.w. linear repeating
disaccharide--D-glucuronyl--D-n-acetylglucosamine
and is the major extracellular glycosaminoglycan found in almost all
types of extracellular matrix, including RA synovium
(22, 23, 24). The nonaggregated form of hyaluronan is
continuously secreted into the joint space by elements of the synovium.
The presence of short chain molecules of hyaluronan in the synovium is
due to degradation after synthesis (25, 26). Our present
results show that fragmented hyaluronan was more effective in
Fas-mediated apoptosis of RA synovial cells than native hyaluronan.
These results suggest that hyaluronan, especially the degraded form, is
far from an inert space filler, but has important biological activities
such as regulation of Fas-mediated apoptosis. IL-1 and TNF- are
also known to induce Fas expression. For instance, exposure of
islet cells to IL-1 induces Fas expression on the cells through the
production of nitrogen oxide (9, 20). IL-1 and TNF-
are abundantly produced in RA synovium and play a central role in the
process of rheumatoid synovitis. However, engagement of CD44 on RA
synovial cells up-regulated Fas expression, which reached maximum
levels within 3 h, whereas IL-1 and TNF- did not in the same
kinetics. Furthermore, other reports indicate that IL-1 and TNF-
rather inhibit Fas-mediated apoptosis of RA synovial cells (27, 28). Thus, CD44 stimulation might function in a different
signaling manner from inflammatory cytokines in synovial cells.
We have previously reported that CD44 cross-linking on RA synovial cells enhances their adhesion to T cells by up-regulation of VCAM-1 (13). Our previous report and current data imply that CD44-mediated signaling augments adhesion of T cells with synovial cells through VLA-4/VCAM-1 pathway, resulting in more efficient interaction through surface molecules such as Fas/Fas ligand (FasL) pathway. T cells, including autoreactive T cell clones, are known to play a central role in an initiation of RA synovitis. However, in chronic and proliferating RA synovium, the significance of T cell functions for the persistent inflammation is unclear. Several reports suggest that T cells in RA synovium might not be so active, less amounts of both cell surface activation Ags and cytokine production (29, 30). In SCID mouse model of RA, depletion of T cells rather amplifies synovial cell proliferation, the growth of pannus, and subsequent degradation of bones (31). Furthermore, a minority of patients have to date benefited from the therapy using anti-CD4 mAb, which failed to control growth of synovium in vivo (32, 33). These reports suggest that T cells might rather restrain hyperplasia of the synovial membrane in chronic RA synovitis. Several reports demonstrated that FasL gene transfer to RA synovium induces remarkable apoptosis to synovial cells through Fas/FasL pathway (34, 35, 36). These reports and our current data suggest that ligation of CD44, highly expressed on synovial cells, by surrounding hyaluronan enhances adhesion and interaction of synovial cells with synovial FasL-positive cells, resulting in amplified apoptosis of synovial cells through Fas/FasL pathway. In vivo, synovial cells are surrounded by and encounter extracellular matrix such as hyaluronan mainly through their receptors, including CD44, indicating that the engagement of CD44 by matrix protein always occurs in RA synovium. However, several possibilities are raised, for example, soluble Fas, soluble VCAM-1/ICAM-1, and soluble CD44 might interfere with the interaction of RA synovial cells and T cells, which may inhibit Fas/FasL-mediated apoptosis of RA synovial cells (38, 39, 40). Hyperplasia of RA synovial cells may result from the incomplete apoptosis of synovial cells, despite abundant Fas expression.
Taken together, these results indicate that CD44 is deeply concerned in Fas expression and Fas-mediated apoptosis of RA synovial cells in the following novel characteristics: 1) the involvement of cell surface functional molecules per se (in this study, CD44), in the induction or amplification of other functional molecules (in this study, Fas) on the same cell; 2) interaction of CD44 and degraded products of hyaluronan play an important role in biological activities, such as induction of apoptosis; 3) CD44-mediated signaling might be different from cytokine-mediated one in regulating Fas expression and Fas-mediated apoptosis; 4) CD44 further augments Fas/FasL-mediated apoptosis of synovial cells by augmenting the adhesion of synovial cells with T cells through up-regulation of VCAM-1 on synovial cells. Several clinical studies are underway to test various strategies to regulate activation of the synovial cells in RA patients, and the rational design of future therapeutic strategies for RA synovitis may thereby include the exploitation of CD44 and Fas death pathway to directly reduce growth of synovial cells in vivo.
|
Acknowledgments |
|---|
|
Footnotes |
|---|
2 Address correspondence and reprint requests to Dr. Yoshiya Tanaka, First Department of Internal Medicine, University of Occupational and Environmental Health, Japan, School of Medicine, 1-1 Iseigaoka, Yahatanishi-ku, Kitakyushu 807-8555 Japan. E-mail address: tanaka{at}med.uoeh-u.ac.jp
3 Abbreviations used in this paper: RA, rheumatoid arthritis; FasL, Fas ligand; PI, propidium iodide.
Received for publication March 21, 2000. Accepted for publication May 18, 2001.
|
References |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
4/1 integrin (VLA-4) ligands in arthritis: vascular cell adhesion molecule-1 expression in synovium and on fibroblast-like synoviocytes. J. Immunol. 149:1424.[Abstract]
transcription. J. Immunol. 157:5097.[Abstract]
cells for Fas-mediated destruction in insulin-dependent diabetes mellitus. J. Exp. Med. 186:1193.. Biochem. Biophys. Res. Commun. 218:280.[Medline]
This article has been cited by other articles:
|
|
 |
|
  S. Tsujimura, K. Saito, K. Kohno, and Y. Tanaka Fragmented Hyaluronan Induces Transcriptional Up-regulation of the Multidrug Resistance-1 Gene in CD4+ T Cells J. Biol. Chem., December 8, 2006; 281(49): 38089 - 38097. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. N. Sugahara, T. Hirata, H. Hayasaka, R. Stern, T. Murai, and M. Miyasaka Tumor Cells Enhance Their Own CD44 Cleavage and Motility by Generating Hyaluronan Fragments J. Biol. Chem., March 3, 2006; 281(9): 5861 - 5868. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. M.A. Rouschop, N. Claessen, S. T. Pals, J. J. Weening, and S. Florquin CD44 Disruption Prevents Degeneration of the Capillary Network in Obstructive Nephropathy via Reduction of TGF-beta1-Induced Apoptosis J. Am. Soc. Nephrol., March 1, 2006; 17(3): 746 - 753. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. L. Peng Fas (CD95)-related apoptosis and rheumatoid arthritis Rheumatology, January 1, 2006; 45(1): 26 - 30. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. E. Hunt and D. R. Brown Mycoplasma alligatoris Infection Promotes CD95 (FasR) Expression and Apoptosis of Primary Cardiac Fibroblasts Clin. Vaccine Immunol., December 1, 2005; 12(12): 1370 - 1377. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. P. Mishra, S. Mishra, K. Gee, and A. Kumar Differential Involvement of Calmodulin-dependent Protein Kinase II-activated AP-1 and c-Jun N-terminal Kinase-activated EGR-1 Signaling Pathways in Tumor Necrosis Factor-{alpha} and Lipopolysaccharide-induced CD44 Expression in Human Monocytic Cells J. Biol. Chem., July 22, 2005; 280(29): 26825 - 26837. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. S. Hauptschein, K. E. Sloan, C. Torella, R. Moezzifard, M. Giel-Moloney, C. Zehetmeier, C. Unger, L. L. Ilag, and D. G. Jay Functional Proteomic Screen Identifies a Modulating Role for CD44 in Death Receptor-Mediated Apoptosis Cancer Res., March 1, 2005; 65(5): 1887 - 1896. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. J. McKallip, M. Fisher, U. Gunthert, A. K. Szakal, P. S. Nagarkatti, and M. Nagarkatti Role of CD44 and Its v7 Isoform in Staphylococcal Enterotoxin B-Induced Toxic Shock: CD44 Deficiency on Hepatic Mononuclear Cells Leads to Reduced Activation-Induced Apoptosis That Results in Increased Liver Damage Infect. Immun., January 1, 2005; 73(1): 50 - 61. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Krettek, G. K. Sukhova, U. Schonbeck, and P. Libby Enhanced Expression of CD44 Variants in Human Atheroma and Abdominal Aortic Aneurysm: Possible Role for a Feedback Loop in Endothelial Cells Am. J. Pathol., November 1, 2004; 165(5): 1571 - 1581. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Takeda, H. Terasawa, M. Sakakura, Y. Yamaguchi, M. Kajiwara, H. Kawashima, M. Miyasaka, and I. Shimada Hyaluronan Recognition Mode of CD44 Revealed by Cross-saturation and Chemical Shift Perturbation Experiments J. Biol. Chem., October 31, 2003; 278(44): 43550 - 43555. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Gee, M. Kozlowski, and A. Kumar Tumor Necrosis Factor-{alpha} Induces Functionally Active Hyaluronan-adhesive CD44 by Activating Sialidase through p38 Mitogen-activated Protein Kinase in Lipopolysaccharide-stimulated Human Monocytic Cells J. Biol. Chem., September 26, 2003; 278(39): 37275 - 37287. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X.-M. Xu, Y. Chen, J. Chen, S. Yang, F. Gao, C. B. Underhill, K. Creswell, and L. Zhang A Peptide with Three Hyaluronan Binding Motifs Inhibits Tumor Growth and Induces Apoptosis Cancer Res., September 15, 2003; 63(18): 5685 - 5690. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. N. Sugahara, T. Murai, H. Nishinakamura, H. Kawashima, H. Saya, and M. Miyasaka Hyaluronan Oligosaccharides Induce CD44 Cleavage and Promote Cell Migration in CD44-expressing Tumor Cells J. Biol. Chem., August 22, 2003; 278(34): 32259 - 32265. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. S. Davis A Question of Transformation: The Synovial Fibroblast in Rheumatoid Arthritis Am. J. Pathol., May 1, 2003; 162(5): 1399 - 1402. [Full Text] [PDF]
|
|
|
|
|
|
W. R. Waters, T. E. Rahner, M. V. Palmer, D. Cheng, B. J. Nonnecke, and D. L. Whipple Expression of L-Selectin (CD62L), CD44, and CD25 on Activated Bovine T Cells Infect. Immun., January 1, 2003; 71(1): 317 - 326. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. J. McKallip, Y. Do, M. T. Fisher, J. L. Robertson, P. S. Nagarkatti, and M. Nagarkatti Role of CD44 in activation-induced cell death: CD44-deficient mice exhibit enhanced T cell response to conventional and superantigens Int. Immunol., September 1, 2002; 14(9): 1015 - 1026. [Abstract] [Full Text] [PDF]
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
);
anti-CD44 mAb, NIH44-1 (
); and anti-ICAM-1 mAb, 84H10 (
),
at a concentration of 10 µg/ml for 3 h. Fas expression was
analyzed by FACScan. Each value represents the number of molecules
expressed per cell, calculated using standard QIFKIT beads, as
described in Materials and Methods. Data are mean
± SD. *, p < 0.05 compared with controls.
